Ashleen Shadeo

723 citations
13 papers · 584 indexed · h-index 11
Topics
Cervical Cancer and HPV Research (2 papers)Genomic variations and chromosomal abnormalities (2 papers)RNA modifications and cancer (2 papers)

In The Last Decade

Ashleen Shadeo

12 papers receiving 575 citations

Peers

Ashleen Shadeo
Comparison fields: 5 of 60
  • Molecular Biology 399
  • Cancer Research 162
  • Oncology 158
  • Genetics 82
  • Pathology and Forensic Medicine 76
Replace M Kashiwaba with:
M Kashiwaba Japan
Steve Baylin United States
Kosaku Uchida Japan
Mandy Boer Netherlands
Itaru Sonoda Japan
Sabine Franke Germany
Emmanuel Tubacher France
Karen To Canada
Mirko Müller Germany
J.M. Trent United States
Ashleen Shadeo relative to M Kashiwaba Japan M Kashiwaba's profile →
Citations per field
00.5×1.6×
M Kashiwaba · 1×
Citations per year

Countries citing papers authored by Ashleen Shadeo

Since Specialization
Citations

This map shows the geographic impact of Ashleen Shadeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleen Shadeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleen Shadeo more than expected).

Fields of papers citing papers by Ashleen Shadeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashleen Shadeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleen Shadeo. The network helps show where Ashleen Shadeo may publish in the future.

Co-authorship network of co-authors of Ashleen Shadeo

This figure shows the co-authorship network connecting the top 25 collaborators of Ashleen Shadeo. A scholar is included among the top collaborators of Ashleen Shadeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashleen Shadeo. Ashleen Shadeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 81
2 64
3 28
4
Comprehensive serial analysis of gene expression of the cervical epithelium transcriptome
1
5 122
6 18
7 10
8 72
9 57
10 48
11 52
12 30
13 1

About Ashleen Shadeo

Ashleen Shadeo is a scholar working on Aging, Cancer Research and Oncology, having authored 13 papers that have together received 584 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (2 papers), Genomic variations and chromosomal abnormalities (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (162 citations), Molecular Biology (399 citations) and Oncology (158 citations). Ashleen Shadeo has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Wan L. Lam, Anna L. Stratford, Sandra E. Dunn, Arezoo Astanehe, Peter R. Mertens, Helen Jiang, Torsten O. Nielsen, Marco A. Marra, Karen To and Abbas Fotovati. Their work appears in journals such as The Journal of Immunology, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026